Compositions and methods for promoting a healthy microbial flora in a mammal
AssigneeBIOHM Health LLC
InventorAfif Ghannoum
Life of this patent
Estimating the term…
Loading patent…
AssigneeBIOHM Health LLC
InventorAfif Ghannoum
Estimating the term…
The disclosure provides compositions and dosage forms for promoting healthy microbial flora in a mammal, for example, a human. The disclosure further provides compositions and dosage forms for disrupting biofilm or preventing formation of biofilm containing pathogenic bacteria and/or pathogenic fungi in a particular region of a subject. The dosage forms contain (i) an isolated non-pathogenic fungal strain that is viable in the region of the subject, (ii) an isolated non-pathogenic bacterial strain that is viable in the region of the subject, and optionally (iii) an enzyme capable of disrupting the biofilm. The present disclosure also provides methods of disrupting a biofilm or preventing formation of a biofilm with such a composition or dosage form, methods of identifying a subject suitable for treatment with such a composition or dosage form, and methods of improving nutrient absorption using such a composition or dosage form.
A biofilm disrupting composition comprising (i) a freeze dried or spray dried blend comprising an isolated and viable non-pathogenic fungal strain and three different isolated and viable non-pathogenic bacterial strains and (ii) an amylase enzyme capable of disrupting a biofilm in a subject, wherein the isolated and viable non-pathogenic fungal strain is Saccharomyces boulardii and the three isolated and viable non-pathogenic bacterial strains are Lactobacillus rhamnosus, Bifidobacterium breve, and Lactobacillus acidophilus.
A dosage form capable of disrupting a biofilm comprising a pathogenic bacteria and a pathogenic fungus disposed within a preselected region of a subject, the dosage form comprising a composition comprising (i) an amylase enzyme capable of disrupting the biofilm and (ii) a freeze dried or spray dried blend comprising a non-pathogenic fungal strain capable of replicating in the region of the subject and three different isolated and viable non-pathogenic bacterial strains capable of replicating in the region of the subject, wherein the isolated and viable non-pathogenic fungal strain is Saccharomyces boulardii and the three isolated and viable non-pathogenic bacterial strains are Lactobacillus rhamnosus, Bifidobacterium breve, and Lactobacillus acidophilus.
Dependencies are inferred from the claim text.